FdaApplication
NDA 217150
Identifiers
- fda_app_no: NDA217150
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 2023-09-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 1GM/10ML (100MG/ML) | SOLUTION;INTRAVENOUS |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 500MG/5ML (100MG/ML) | SOLUTION;INTRAVENOUS |
| CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 2GM/20ML (100MG/ML) | SOLUTION;INTRAVENOUS |
3 products